➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Express Scripts
McKinsey
McKesson
Johnson and Johnson

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Clioquinol


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Clioquinol?

Clioquinol is an investigational drug.

There have been 3 clinical trials for Clioquinol. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.

The most common disease conditions in clinical trials are Leukemia, Lymphoid, Myelodysplastic Syndromes, and Leukemia, Lymphocytic, Chronic, B-Cell. The leading clinical trial sponsors are EMS, University Health Network, Toronto, and University Hospital, Lille.

Recent Clinical Trials for Clioquinol
TitleSponsorPhase
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis EczematousEMSPhase 3
Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's DiseaseUniversity Hospital, LillePhase 2/Phase 3
Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyUniversity Health Network, TorontoPhase 1

See all Clioquinol clinical trials

Clinical Trial Summary for Clioquinol

Top disease conditions for Clioquinol
Top clinical trial sponsors for Clioquinol

See all Clioquinol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Baxter
Express Scripts
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.